A study to evaluate the clinical performance of the Bisoprolol in post myocardial infarction patients
- Conditions
- Health Condition 1: I252- Old myocardial infarction
- Registration Number
- CTRI/2020/05/025009
- Lead Sponsor
- Dr Kamal Sharma
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 0
Post MI (NSTEMI & STEMI) patients with systolic LV dysfunction (HFmEF&HFrEF i.e. LVEF < 50%)
Patients prescribed with oral Bisoprolol (Concor) during or on discharge from the index hospitalization between 1st August 2016 to 30th November 2018 and follow-up data for up to 1 year from date of discharge and initiation of treatment under consideration, is available
Consent for data collection
Age <18 at hospitalization
Patients with Beta Blocker other than bisoprolol at the index date
Patients who leave against medical advice during the hospitalization for MIwith incomplete revascularization.
Patients who die during hospitalization for MI
Patients presenting with high grade II degree and III degree AV block at the index date (contra-indication to beta-blockers)
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Measure mean changes in heart rate from baseline at the time of index event of hospitalization and at 1 year duration follow-upTimepoint: Baseline and 12 months
- Secondary Outcome Measures
Name Time Method